Product logins

Find logins to all Clarivate products below.


Transcatheter Embolization and Occlusion Devices | Market Insights | Asia Pacific | 2022

While the COVID-19 pandemic will have a negative but limited impact on the Asia Pacific transcatheter embolization and occlusion device market in the short term, the market will expand at a strong rate over the forecast period, driven by adoption of innovative and premium-priced products, incremental device improvements, as well as rising penetration of endovascular embolization in new indications.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for TEO devices in the Asia Pacific region across a 11-year period.

Related Medtech Insights Reports

Report
Diabetes Care Devices – Market Insights – Asia Pacific
The Asia Pacific diabetes care device market is expected to experience moderate growth over the forecast period, driven by a rising diabetes population, untapped market opportunities, regulatory…
Report
Laparoscopic Devices – Market Insights – Asia Pacific
The Asia Pacific laparoscopic device market will experience modest growth through 2034. Growth over the forecast period will be driven mainly by the continued uptake of innovative premium priced…
Report
Trauma Devices – Market Insights – Asia Pacific
The Asia Pacific trauma device market is experiencing steady growth driven by a rising incidence of fractures, an aging population, and increasing rates of road traffic accidents, particularly in…
Report
Transcatheter Embolization and Occlusion Devices – Market Insights – Latin America
The Latin American TEO device market is poised to experience moderate growth through 2034. This growth will be driven by the introduction of newly developed technologies, increasing adoption of…
Report
Transcatheter Embolization and Occlusion Devices | Market Insights | Latin America (Supplemental) | 2023
Although COVID-19 has negatively impacted the Latin American transcatheter embolization and occlusion device market, the impact of COVID-19 has been limited. The market will expand at a modest rate…